Fluoride Supplements, Public Water System [HB-225]
[Healthcare ]
[Public Health ]
[Water ]
An Act relating to prescription fluoride supplements; relating to the practice of pharmacy; and relating to fluoride in public water systems.
HB-225: Fluoride Supplements, Public Water System
Sponsored by: Rep. Jamie D. Allard
Read The First Time - Referrals on 05/10/2025
Pharmacist Prescription Authority [HB-195]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
An Act relating to the prescription and administration of drugs and devices by pharmacists; relating to reciprocity for pharmacists; and providing for an effective date.
HB-195: Pharmacist Prescription Authority
Sponsored by: Rep. Mike Prax
Cosponsor(s): Prax on 05/16/2025
Pharmacist Prescription Authority [SB-147]
[Healthcare ]
[Pharmaceuticals ]
[Public Health ]
An Act relating to the prescription and administration of drugs and devices by pharmacists; relating to reciprocity for pharmacists; and providing for an effective date.
SB-147: Pharmacist Prescription Authority
Sponsored by: Sen. Catherine A. Giessel
L&c Rpt Recd W/cs Await Transmittal Nxt on 05/12/2025
Health Insurance & Pharmacy Benefits Mgrs [SB-142]
[Healthcare ]
[Insurance ]
[Pharmaceuticals ]
[Medicare and Medicaid ]
[Public Health ]
An Act relating to municipal and state group health insurance plans and policies, including self-insured plans and policies, and the administration and management of pharmacy benefits; and providing for an effective date.
SB-142: Health Insurance & Pharmacy Benefits Mgrs
Sponsored by: Sen. Catherine A. Giessel
Read The First Time - Referrals on 03/24/2025
Pharmacy Benefits Manager;3rd Party Admin [HB-149]
[Healthcare ]
[Insurance ]
[Pharmaceuticals ]
An Act relating to pharmacy benefits managers; relating to third-party administrators; and providing for an effective date.
Pharmacy Benefits Manager;3rd Party Admin [SB-134]
[Healthcare ]
[Insurance ]
[Pharmaceuticals ]
An Act relating to pharmacy benefits managers; relating to third-party administrators; and providing for an effective date.
SB-134: Pharmacy Benefits Manager;3rd Party Admin
Sponsored by: Sen. Catherine A. Giessel
Referred To Rules on 05/17/2025
HB-286: Amends existing law to revise provisions regarding board membership and certain qualifications.
Sponsored by: Rep. Health and Welfare Committee
Reported Signed By Governor On March 28, 2025 Session Law Chapter 212 Effective: 07/01/2025 on 03/24/2025
AN ACT relating to reproductive health services. [HB-793]
[Reproductive Rights / Abortion ]
[Healthcare ]
[Medicare and Medicaid ]
[Pharmaceuticals ]
[Public Health ]
[Insurance ]
[Family-Related Legislation ]
[Children and Youth ]
Create a new section of KRS Chapter 211 to define terms; provide rights related to access to contraception; create private right of action; create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for contraception; amend KRS 304.17A-099 to exclude contraception from cost defrayal requirements; require health benefit plans to provide coverage for long-acting reversible contraception administered during a postpartum hospital stay; amend KRS 164.2871, 205.522, 205.6485, and 18A.225 to require self-insured
(continued...)
HB-793: AN ACT relating to reproductive health services.
Sponsored by: Rep. Sarah Stalker
To Banking & Insurance (h) on 02/27/2025
AN ACT relating to liability shield products and declaring an emergency. [HB-648]
[Public Health ]
[Consumer Protection ]
[Healthcare ]
[Pharmaceuticals ]
[Law Enforcement ]
Create a new section of KRS Chapter 217 to define terms; require a manufacturer of a liability shield product to subject the product to a placebo-controlled study before it is manufactured, marketed, distributed, or administered in Kentucky; establish requirements for the placebo-controlled study; require the Cabinet for Health and Family Services to monitor and track adverse outcomes of liability shield products; require manufacturers of liability shield products to submit documentation to the cabinet of the placebo-controlled study and results
(continued...)
HB-648: AN ACT relating to liability shield products and declaring an emergency.
Sponsored by: Rep. Savannah Maddox
To Health Services (h) on 02/26/2025
A JOINT RESOLUTION directing the Cabinet for Health and Family Services to implement an in-home-drug disposal pilot program. [HJR-37]
[Healthcare ]
[Public Health ]
[Pharmaceuticals ]
[Overdose Prevention ]
Direct the Cabinet for Health and Family Services to implement a pilot program beginning January 1, 2026, to study the effectiveness of in-home prescription drug disposal in Kentucky; require consultation with the Board of Pharmacy; require submission of a report to the Interim Joint Committee on Health Services by December 1, 2027.
HJR-37: A JOINT RESOLUTION directing the Cabinet for Health and Family Services to implement an in-home-drug disposal pilot program.
Sponsored by: Rep. Robert B. Duvall
To Health Services (h) on 02/27/2025
AN ACT relating to health care. [HB-688]
[Healthcare ]
[Public Health ]
[Education ]
[Pharmaceuticals ]
[Law Enforcement ]
[Children and Youth ]
[Disabilities ]
[Crime ]
Amend KRS 314.041, relating to registered nurse licensure, and KRS 314.051, relating to licensed practical nurse licensure, to permit rather than require the board to issue credentials; amend KRS 314.042 to require physicians collaborating with an advanced practice registered nurse to have an active and unrestricted license in Kentucky; amend KRS 314.109 to reduce the time from 90 to 30 days for a person under the jurisdiction of the board to notify the board of a conviction of certain misdemeanors or felonies; amend KRS 209.032, relating to employees
(continued...)
HB-688: AN ACT relating to health care.
Sponsored by: Rep. Kimberly Poore Moser
2nd Reading, To Rules on 03/12/2025
AN ACT relating to pharmaceutical drugs. [HB-501]
[Pharmaceuticals ]
[Healthcare ]
[Public Health ]
Create a new section of KRS Chapter 315 to establish requirements for pharmacists when dispensing prescriptions in the event of a practitioner's death.
HB-501: AN ACT relating to pharmaceutical drugs.
Sponsored by: Rep. Derek Lewis
Became Law Without Governor's Signature (acts Ch. 161) on 04/10/2025
AN ACT relating to human gene therapy products and declaring an emergency. [HB-469]
[Healthcare ]
[Public Health ]
[Science ]
[Pharmaceuticals ]
Create a new section of KRS Chapter 214 to establish legislative intent; define terms; establish that a person in the Commonwealth shall not administer, by any route or modality, any human gene therapy product for any infectious disease indication, regardless of whether the administration is termed an immunization, vaccine, or any other term; exempt human gene therapy products used to treat cancer or genetic disorders; sunset the provisions on July 1, 2035, unless extended by the General Assembly; EMERGENCY.
HB-469: AN ACT relating to human gene therapy products and declaring an emergency.
Sponsored by: Rep. Mark Hart
To Health Services (h) on 02/14/2025